Robert Georgantas - Mar 10, 2022 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Chief Scientific Officer
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Robert Georgantas III
Stock symbol
BDSX
Transactions as of
Mar 10, 2022
Transactions value $
$0
Form type
4
Date filed
3/14/2022, 05:56 PM
Previous filing
Feb 10, 2022
Next filing
May 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Stock Options (Right to buy) Award $0 +22.7K $0.00 22.7K Mar 10, 2022 Common Stock 22.7K $2.29 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.